PIK3CA and colorectal cancer: For example, one study indicated that patients with stage IV carrying exon 20 mutations had significantly shorter OS compared to wild-type patients, and in a multivariate COX regression model, PIK3CA exon 20 mutations were significantly associated with reduced OS in stage IV colorectal cancer patients (Fu et al., 2021).